fludarabine has been researched along with Bone Neoplasms in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chauvin-Fleurence, CN; Courtney, AN; Dakhova, O; Di Pierro, EJ; Dotti, G; Ghatwai, N; Heczey, A; Li, M; Liu, B; Liu, K; Metelitsa, LS; Montalbano, A; Ngai, H; Raveh-Sadka, T; Robinson, S; Savoldo, B; Xu, X | 1 |
| Acar, H; Aydemir, E; Bayrak, OF; Gulluoglu, S; Ozen, M; Sahin, F; Sevli, S; Yalvac, ME | 1 |
| Langiewicz, P; Rzepecki, P; Sarosiek, T; Szczylik, C; Zolnierek, J | 1 |
| Ijichi, O; Ikarimoto, N; Ishikawa, S; Kawano, Y; Kodama, Y; Manago, K; Nishikawa, T; Okamoto, Y; Shinkoda, Y; Tanabe, T | 1 |
2 trial(s) available for fludarabine and Bone Neoplasms
| Article | Year |
|---|---|
Anti-GD2 CAR-NKT cells in patients with relapsed or refractory neuroblastoma: an interim analysis.
Topics: Bone Neoplasms; Child; Cyclophosphamide; Drug Resistance, Neoplasm; Humans; Immunity; Immunotherapy, Adoptive; Lymphocyte Activation; Male; Natural Killer T-Cells; Neuroblastoma; Receptors, Antigen, T-Cell; Receptors, Chimeric Antigen; Vidarabine | 2020 |
Allogeneic non-myeloablative hematopoietic stem cell transplantation for treatment of metastatic renal cell carcinoma -- single center experience.
Topics: Adult; Bone Neoplasms; Brain Neoplasms; Carcinoma, Renal Cell; Cyclophosphamide; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Kidney Neoplasms; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Transplantation Conditioning; Vidarabine | 2005 |
2 other study(ies) available for fludarabine and Bone Neoplasms
| Article | Year |
|---|---|
The effects of chemotherapeutic agents on differentiated chordoma cells.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Benzamides; Bone Neoplasms; Cell Differentiation; Cell Line, Tumor; Cell Lineage; Chordoma; Cisplatin; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Humans; Imatinib Mesylate; Methotrexate; Piperazines; Pyrimidines; Vidarabine; Vincristine | 2011 |
Rapid progression of metastatic osteosarcoma after initiation of a reduced-intensity conditioning regimen with immunosuppressive fludarabine.
Topics: Antineoplastic Agents; Bone Neoplasms; Child; Disease Progression; Fatal Outcome; Female; Humans; Immunosuppression Therapy; Magnetic Resonance Imaging; Myeloablative Agonists; Osteosarcoma; Pleural Neoplasms; Radiography, Thoracic; Vidarabine | 2006 |